- Home
- Life Sciences
- Traumatic Brain Injury Assessment and Management Devices
Traumatic Brain Injury Assessment And Management Devices Market Research Report – Segmented By Region (North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America) – Analysis on Size, Share, Trends, COVID-19 Impact, Competitive Analysis, Growth Opportunities and Key Insights from 2019 to 2030.
-
Published date -30th Jan 2024
-
Formats -PDF, CSV
-
Region -Global
Anticoccidial Drugs Market Size (2021 to 2030)
The global anticoccidial drugs market is expected to have a growth rate of 3.61% CAGR from 2021 to 2030. As a result, the market is anticipated to grow by USD 1691.94 Million by 2028.
Anticoccidial Drugs Market Share Insights:
Based on the Drug type, the ionophore anticoccidials segment had the largest market share of the global anticoccidial drugs market in 2022. Based on animal type, the poultry animal segment had the largest market share of the global anticoccidial drugs market in 2022.
Impact of COVID-19 on the global anticoccidial drugs market:
The disease has spread to almost every country globally since the COVID-19 virus outbreak in December 2019, prompting the World Health Organization to declare it a public health emergency.
Market Drivers:
YOY growth in the prevalence of coccidiosis and increasing focus on animal health primarily accelerates the global anticoccidial drugs market. Anticoccidial drugs are the agents used to treat, prevent, and control coccidial infections.
Market Restraints:
However, the need for more skilled persons in manufacturing appropriate drugs with correct dosage forms slowly restricts the global anticoccidial drug market.
Anticoccidial Drugs Market - By Drug Type:
Antibiotic Anticoccidials, Ionophore Anticoccidials, Chemical Derivative Anticoccidials
Anticoccidial Drugs Market - By Animal Type:
Poultry, Swine, Fish, Cattle, Companion Animal
Anticoccidial Drugs Market - By Region:
North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Key Market Players:
Noteworthy companies in the global anticoccidial drugs market profiled in this report are Bayer Health care, Zoetis, Elanco, Merial, Merck Animal Healthcare, Ceva Santé Animale, Virbac, Boehringer Ingelheim Animal Health, Novartis Animal Healthcare, and Smartvet Inc.
Recent Developments in the Market:
- In April 2022, Amlan International, a U.S.-based company operating in veterinary healthcare, announced natural alternatives to anticoccidial drugs.
- In May 2020, Zoetis showed suckling calves with significant weight gain from implants.
- In September 2019, Virbac launched Multimin, which is used for cattle.
- In October 2019, Ceva Sante Animale agreed with ProBioGen, the manufacturer, to represent a transformation of poultry vaccines with the help of ProBioGen's proprietary AGE1.CR technology.
